Tinea Pedis Treatment Market 2017 Trend, Analysis and Forecast to 2021
ReportsWeb.com published “Tinea Pedis Treatment Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
(EMAILWIRE.COM, June 22, 2017 ) Tinea pedis, also known as athlete's foot, is caused by dermatophyte fungus on foot and can spread to toenails and hands. It is a dermatophyte infection of the soles of the feet and the interdigital spaces. Tinea pedis thrives in warm, humid conditions and is most common among young adult men. Tinea pedis can be transmitted through direct contact with an infected person or by touching surfaces contaminated with the fungus. This fungus lives in warm, moist environments and is found in showers, locker room floors, and swimming pools.
Publisher's analysts forecast the global tinea pedis treatment market to grow at a CAGR of 3.03% during the period 2017-2021.
For more information about this report: http://www.reportsweb.com/global-tinea-pedis-treatment-market-2017-2021 .
Covered in this report
The report covers the present scenario and the growth prospects of the global tinea pedis treatment market for 2017-2021. To calculate the market size, the report considers the sales of both branded and generic drugs sales.
The market is divided into the following segments based on geography:
-Americas
-APAC
-EMEA
Publisher's report, Global Tinea Pedis Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
-GSK
-Exeltis USA
-Valeant
-Viamet Pharmaceuticals
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001841211/sample .
Other prominent vendors
-Allergan
-Almirall
-Amgen
-Aqua Pharmaceuticals
-AstraZeneca
-Bayer
-Bristol-Myers Squibb
-Celgene
-Dermira
-Elorac
-F. Hoffmann-La Roche
-Galderma
-Genentech
-Hexima
-Hisamitsu Pharmaceutical
-Incyte
-Mayne Pharma
-MediQuest Therapeutics
-Meiji Seika Pharma
-Merz Pharmaceuticals
-Moberg Pharma
-Mylan Pharmaceuticals
-NanoBio
-NovaBiotics
-Novan
-Nuvo Research
-Polichem
-Promius Pharma
-Sanofi
-Seren Pharmaceuticals
-Sun Pharma
-Taro
-Teva Pharmaceutical
-Theravance Biopharma
-Tinea Pharmaceuticals
Market driver
-High unmet needs
-For a full, detailed list, view our report
Market challenge
-Increased availability of generics and alternative therapies
-For a full, detailed list, view our report
Market trend
-Increased funding for antifungal research
-For a full, detailed list, view our report
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001841211/buying .
Publisher's analysts forecast the global tinea pedis treatment market to grow at a CAGR of 3.03% during the period 2017-2021.
For more information about this report: http://www.reportsweb.com/global-tinea-pedis-treatment-market-2017-2021 .
Covered in this report
The report covers the present scenario and the growth prospects of the global tinea pedis treatment market for 2017-2021. To calculate the market size, the report considers the sales of both branded and generic drugs sales.
The market is divided into the following segments based on geography:
-Americas
-APAC
-EMEA
Publisher's report, Global Tinea Pedis Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
-GSK
-Exeltis USA
-Valeant
-Viamet Pharmaceuticals
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001841211/sample .
Other prominent vendors
-Allergan
-Almirall
-Amgen
-Aqua Pharmaceuticals
-AstraZeneca
-Bayer
-Bristol-Myers Squibb
-Celgene
-Dermira
-Elorac
-F. Hoffmann-La Roche
-Galderma
-Genentech
-Hexima
-Hisamitsu Pharmaceutical
-Incyte
-Mayne Pharma
-MediQuest Therapeutics
-Meiji Seika Pharma
-Merz Pharmaceuticals
-Moberg Pharma
-Mylan Pharmaceuticals
-NanoBio
-NovaBiotics
-Novan
-Nuvo Research
-Polichem
-Promius Pharma
-Sanofi
-Seren Pharmaceuticals
-Sun Pharma
-Taro
-Teva Pharmaceutical
-Theravance Biopharma
-Tinea Pharmaceuticals
Market driver
-High unmet needs
-For a full, detailed list, view our report
Market challenge
-Increased availability of generics and alternative therapies
-For a full, detailed list, view our report
Market trend
-Increased funding for antifungal research
-For a full, detailed list, view our report
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001841211/buying .
Contact Information:
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results